The Association pursues the following objectives:

• Implement policies to support individuals affected by AE and their families, ensuring that families are not the sole care/case managers for patients, particularly in the case of minors;
• Protect individuals affected by AE by facilitating access to services and information necessary to guarantee their rights as patients and promote their inclusion in school and work environments;
• Support and promote scientific research through rigorous scientific methods to consolidate results within mainstream medicine;
• Promote, by actively participating in public debate, the discussion and dissemination of information on health, welfare, and social issues, contributing to mitigating or reducing the lack of medical or health information;
• Support and promote scientific research through rigorous scientific methods to consolidate results within mainstream medicine;
• Promote awareness and study of these diseases to raise public awareness and encourage national, European, and international institutions to develop Integrated Diagnostic-Therapeutic-Assistance Pathways (PDTA) with the goal of improving health conditions and quality of life, while safeguarding the rights of patients, families, and caregivers in appropriate venues;
• Advocate for the legislative recognition of free access to treatments and medications by supporting the inclusion of rare immune disorders of the central nervous system in both the Essential Levels of Assistance (LEA) and the National Chronicity Plan, and promoting nationwide diagnosis and therapy;
• Promote and support the inclusion of these syndromes in the National Rare Disease Registry, given their prevalence, to improve the mapping of cases across the country and facilitate the collection of epidemiological, clinical, and healthcare data regarding these conditions;
• Raise awareness of treatment advancements and best practices adopted in other countries, help understand the needs of patients and their families, encourage transparency and clarity in communicating methodologies, protocols, cases, and short- and long-term results, and foster the creation of specific care pathways;
• Promote the adoption of national and international guidelines for rare immune disorders of the central nervous system, developed in collaboration with health and social workers, patient associations, and their families;
• Encourage public entities to ensure that emergency medical personnel are trained to promptly recognize and diagnose the condition and provide accurate and timely guidance.